AXL (AXL receptor tyrosine kinase) is associated with EMT in several tumours and its upregulation in the Hedgehog pathway has been recognized as a mechanism of resistance to targeted drugs in EGFR-mutated NSCLC [176]. This evidence concerns the gene EGFR and neoplasm.